Literature DB >> 19869670

THE TRANSFORMATION OF PNEUMOCOCCAL TYPES : II. THE INTERCONVERTIBILITY OF TYPE-SPECIFIC S PNEUMOCOCCI.

M H Dawson1.   

Abstract

1. Type-specific S pneumococci may be transformed from one specific S type into other specific S types through the intermediate stage of the R form. 2. R forms of pneumococi, derived from any specific S type, may be transformed into S organisms of other specific types by the following procedure:-The subcutaneous injection, in white mice, of small amounts of living R forms together with vaccines of heterologous S cultures. (i) S vaccines heated for 15' at temperatures between 60 degrees and 80 degrees C., are effective in causing R forms, derived from heterologous S types, to revert to the type of the vaccine. (ii) S vaccines heated for 15' at temperatures between 80 degrees and 100 degrees C., are not effective in causing R forms, derived from heterologous S types, to revert to the type of the vaccine. (iii) S vaccines heated for 15' at temperatures between 80 degrees and 100 degrees C., may cause 2 R and 3 R cultures to revert to their original S type. (iv) S vaccines of any type, including Type I, heated for 15' at temperatures between 80 degrees and 100 degrees C., are not effective in causing 1 R cultures to revert to their original S type. (v) S vaccines heated for periods as long as two hours at 60 degrees C. are effective in causing R forms, derived from heterologous types, to revert to the type of the vaccine. 3. A single cell R strain, derived from a Type II S pneumococcus, has been successively transformed into a Type III S, a Type I S and a Group IV S culture. 4. Corresponding with the various degrees of "degradation" of the R form there are varying degrees of "development" of the S form. 5. The nature of the conditions responsible for alteration of type as induced by these procedures has been investigated and the causes responsible for the transformations are discussed. 6. All attempts to produce transformation of type in vitro have been unsuccessful. 7. The rô1e which the phenomenon of transformation of type may play in problems of infection and epidemiology is indicated.

Entities:  

Year:  1930        PMID: 19869670      PMCID: PMC2131805          DOI: 10.1084/jem.51.1.123

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  A SIMPLE METHOD FOR THE ISOLATION OF PURE CULTURES FROM SINGLE BACTERIAL CELLS.

Authors:  R C Avery; S J Leland
Journal:  J Exp Med       Date:  1927-05-31       Impact factor: 14.307

2.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

3.  STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VI. THE SPECIFIC EFFECT OF PNEUMOCOCCUS SOLUBLE SUBSTANCE ON THE GROWTH OF PNEUMOCOCCI IN NORMAL SERUM-LEUCOCYTE MIXTURES.

Authors:  R H Sia
Journal:  J Exp Med       Date:  1926-04-30       Impact factor: 14.307

4.  THE INTERCONVERTIBILITY OF "R" AND "S" FORMS OF PNEUMOCOCCUS.

Authors:  M H Dawson
Journal:  J Exp Med       Date:  1928-03-31       Impact factor: 14.307

5.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.

Authors:  M Heidelberger; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

6.  THE PRODUCTION OF PURPURA BY DERIVATIVES OF PNEUMOCOCCUS : III. FURTHER STUDIES ON THE NATURE OF THE PURPURA-PRODUCING PRINCIPLE.

Authors:  L A Julianelle; H A Reimann
Journal:  J Exp Med       Date:  1927-03-31       Impact factor: 14.307

7.  THE SOLUBLE SPECIFIC SUBSTANCE OF FRIEDLANDER'S BACILLUS : PAPER II. CHEMICAL AND IMMUNOLOGICAL RELATIONSHIPS OF PNEUMOCOCCUS TYPE II AND OF A STRAIN OF FRIEDLANDER'S BACILLUS.

Authors:  O T Avery; M Heidelberger; W F Goebel
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

8.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

  8 in total
  12 in total

1.  Streptococcus pneumoniae Elaborates Persistent and Prolonged Competent State during Pneumonia-Derived Sepsis.

Authors:  Jingjun Lin; Pyunghun Park; Hua Li; Myung Whan Oh; Iwona T Dobrucki; Wawrzyniec Dobrucki; Gee W Lau
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

2.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

Review 3.  A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles.

Authors:  Janine Aucamp; Abel J Bronkhorst; Christoffel P S Badenhorst; Piet J Pretorius
Journal:  Cell Mol Life Sci       Date:  2016-09-20       Impact factor: 9.261

Review 4.  Pneumococcal Capsules and Their Types: Past, Present, and Future.

Authors:  K Aaron Geno; Gwendolyn L Gilbert; Joon Young Song; Ian C Skovsted; Keith P Klugman; Christopher Jones; Helle B Konradsen; Moon H Nahm
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  IN VITRO TRANSFORMATION OF PNEUMOCOCCAL TYPES : I. A TECHNIQUE FOR INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES IN VITRO.

Authors:  M H Dawson; R H Sia
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307

6.  One hundred years of presidents of SAB/ASM: the Rockefeller connection.

Authors:  M McCarty
Journal:  Yale J Biol Med       Date:  1999 Sep-Oct

7.  FURTHER OBSERVATIONS ON THE USE OF PNEUMOCOCCUS EXTRACTS IN EFFECTING TRANSFORMATION OF TYPE IN VITRO.

Authors:  J L Alloway
Journal:  J Exp Med       Date:  1933-01-31       Impact factor: 14.307

8.  Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Inductions of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III.

Authors:  O T Avery; C M MacLeod; M McCarty
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

9.  CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

Authors:  T Francis; W S Tillett
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

10.  Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae.

Authors:  J P Dillard; M W Vandersea; J Yother
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.